Literature DB >> 15820159

Usefulness of Doppler assessment of pulmonary vein and left atrial appendage flow following pulmonary vein isolation of chronic atrial fibrillation in predicting recovery of left atrial function.

Erwan Donal1, Richard A Grimm, Hirotsugu Yamada, Yong Jin Kim, Nassir Marrouche, Andrea Natale, James D Thomas.   

Abstract

Atrial fibrillation (AF) is a widespread condition that causes significant morbidity and mortality. Recently, pulmonary venous (PV) isolation using radiofrequency ablation has been used successfully to exclude the pulmonary venous ostia, resulting in correction of AF. Further, miniaturized high-frequency ultrasound phased-array transducers currently provide Doppler and 2-dimensional imaging during the ablation procedure. We examined atrial function and its determinants using intracardiac echocardiography before and after PV isolation in 45 patients who had chronic AF (56 +/- 11 years old). PV, left atrial (LA) appendage, and mitral and tricuspid flows were recorded. Recovery of booster pump function (defined by the presence of mitral inflow A wave, LA appendage a-wave, and PV A-reversal wave velocities >10 cm/s) was observed in 39 of 45 patients (86.6%). PV flow systolic wave before and after ablation correlated with the degree of LA booster pump function after PV isolation. An early systolic PV flow peak velocity >57.47 cm/s predicted "good" LA booster pump function recovery with 96% specificity. Diastolic LA appendage emptying in AF correlated (p <0.001) and predicted good LA booster pump function with 92% specificity for velocities >46.4 cm/s. Thus, monitoring LA function during PV isolation for chronic AF is feasible. Most patients recovered LA booster pump function immediately after PV isolation, and the degree of recovery correlated with LA reservoir function. Preserved reservoir function during AF is predictive of satisfactory recovery of booster pump function after PV isolation.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2005        PMID: 15820159     DOI: 10.1016/j.amjcard.2004.12.031

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.

Authors:  Xin-Xin Ma; Yue-Li Zhang; Bing Hu; Wen-Jun Jiang; Man Wang; Dong-Yan Zheng; Meng-Ruo Zhu; Xiao-Pei Xue
Journal:  J Interv Card Electrophysiol       Date:  2016-12-12       Impact factor: 1.900

2.  Velocity encoded cardiovascular magnetic resonance to assess left atrial appendage emptying.

Authors:  Kai Muellerleile; Arian Sultan; Michael Groth; Daniel Steven; Boris Hoffmann; Gerhard Adam; Gunnar K Lund; Thomas Rostock; Stephan Willems
Journal:  J Cardiovasc Magn Reson       Date:  2012-06-21       Impact factor: 5.364

3.  Role of echocardiography in atrial fibrillation.

Authors:  Tae-Seok Kim; Ho-Joong Youn
Journal:  J Cardiovasc Ultrasound       Date:  2011-06-30

4.  Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation.

Authors:  Demet Menekşe Gerede; Başar Candemir; Veysel Kutay Vurgun; Siamak Mousavi Aghdam; Aynur Acıbuca; Özgür Ulaş Özcan; Hüseyin Göksülük; Celal Kervancıoğlu; Çetin Erol
Journal:  Anatol J Cardiol       Date:  2015-09-15       Impact factor: 1.596

5.  The prognostic significance of left atrial appendage peak flow velocity in the recurrence of persistent atrial fibrillation following first radiofrequency catheter ablation.

Authors:  Wentao Yang; Qing Zhao; Minghui Yao; Xiangdong Li; Yue Zhang; Chuanbin Liu; Zhaoliang Shan; Yutang Wang
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

6.  Left atrial appendage flow velocity predicts recurrence of atrial fibrillation after catheter ablation: A systematic review and meta-analysis.

Authors:  Pengfei Chen; Yujiao Shi; Jianqing Ju; Deng Pan; Lina Miao; Xiaolin Guo; Zhuhong Chen; Jianpeng Du
Journal:  Front Cardiovasc Med       Date:  2022-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.